Global Medical REIT (GMRE) Stock Forecast & Price Target

Compare

811 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GMRE Analyst Ratings

Moderate Buy

2 Buy

2 Hold

0 Sell

Based on 4 analysts giving stock ratings to

Global

Medical REIT

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GMRE Stock 12 Month Forecast

Average Price Target

$38.38

▲(16.44% Upside)

Based on 4 Wall Street analysts offering 12 month price targets for Global Medical REIT in the last 3 months. The average price target is $38.38 with a high forecast of $41.00 and a low forecast of $35.00. The average price target represents a 16.44% change from the last price of $32.96.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","35":"$35","42":"$42","31.5":"$31.5","38.5":"$38.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$41.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":38.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$38.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,31.5,35,38.5,42],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.12,32.80307692307692,33.48615384615385,34.169230769230765,34.85230769230769,35.535384615384615,36.21846153846154,36.90153846153846,37.58461538461538,38.26769230769231,38.95076923076923,39.63384615384615,40.316923076923075,{"y":41,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.12,32.60153846153846,33.08307692307692,33.56461538461539,34.04615384615384,34.527692307692305,35.00923076923077,35.49076923076923,35.972307692307695,36.45384615384616,36.93538461538462,37.41692307692308,37.89846153846154,{"y":38.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,32.12,32.34153846153846,32.56307692307692,32.784615384615385,33.00615384615384,33.22769230769231,33.449230769230766,33.67076923076923,33.89230769230769,34.113846153846154,34.33538461538461,34.55692307692308,34.77846153846154,{"y":35,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":38.96,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.19,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.73,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.11,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.73,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.61,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.34,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.29,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.02,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.87,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.12,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$41.00

Average Price Target$38.38

Lowest Price Target$35.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Wes Golladay

Robert W. Baird

$45→$41

Hold

24.39%

Upside

Reiterated

11/11/25

Global Medical REIT price target lowered to $41 from $45 at BairdGlobal Medical REIT price target lowered to $41 from $45 at Baird

Barry Oxford

Colliers Securities

$40→$35

Buy

6.19%

Upside

Reiterated

11/04/25

Colliers Securities Remains a Buy on Global Medical REIT (GMRE)

Juan C. Sanabria

BMO Capital

$37.5

Hold

13.77%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Real Estate Companies: Global Medical REIT (NYSE: GMRE) and Goodman Group (Other OTC: GMGSF)

Aaron Hecht

Citizens JMP

$40

Buy

21.36%

Upside

Upgraded

10/13/25

Global Medical REIT upgraded to Outperform from Market Perform at Citizens JMPGlobal Medical REIT upgraded to Outperform from Market Perform at Citizens JMP

Merrill Ross

Compass Point

$10→$50

Buy

51.70%

Upside

Reiterated

09/23/25

Analysts' Top Real Estate Picks: Global Medical REIT (GMRE), Equinix (EQIX)GMRE (Buy, $50.00 PT): Update for 5-for-1 Reverse Split – Global Medical announced a 5-for-1 reverse stock split that took effect on September 22nd, and we are adjusting our price target from $10 pre‐split to $50, post split. Maintain Buy rang.

Austin Wurschmidt

KeyBanc

―

Hold

―

Reiterated

06/24/25

KeyBanc Sticks to Their Hold Rating for Global Medical REIT (GMRE)

Gaurav Mehta

Alliance Global Partners

$47.5→$42.5

Buy

28.94%

Upside

Reiterated

05/29/25

Global Medical REIT (GMRE) Receives a Buy from Alliance Global Partners

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$58.75

Buy

78.25%

Upside

Reiterated

05/08/25

John Massocca

B. Riley Securities

$45

Hold

36.53%

Upside

Reiterated

04/03/25

Global Medical REIT transferred with Neutral rating at B. RileyGlobal Medical REIT transferred with Neutral rating at B. Riley

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Wes Golladay

Robert W. Baird

$45→$41

Hold

24.39%

Upside

Reiterated

11/11/25

Global Medical REIT price target lowered to $41 from $45 at BairdGlobal Medical REIT price target lowered to $41 from $45 at Baird

Barry Oxford

Colliers Securities

$40→$35

Buy

6.19%

Upside

Reiterated

11/04/25

Colliers Securities Remains a Buy on Global Medical REIT (GMRE)

Juan C. Sanabria

BMO Capital

$37.5

Hold

13.77%

Upside

Reiterated

11/04/25

Analysts Offer Insights on Real Estate Companies: Global Medical REIT (NYSE: GMRE) and Goodman Group (Other OTC: GMGSF)

Aaron Hecht

Citizens JMP

$40

Buy

21.36%

Upside

Upgraded

10/13/25

Global Medical REIT upgraded to Outperform from Market Perform at Citizens JMPGlobal Medical REIT upgraded to Outperform from Market Perform at Citizens JMP

Merrill Ross

Compass Point

$10→$50

Buy

51.70%

Upside

Reiterated

09/23/25

Austin Wurschmidt

KeyBanc

―

Hold

―

Reiterated

06/24/25

KeyBanc Sticks to Their Hold Rating for Global Medical REIT (GMRE)

Gaurav Mehta

Alliance Global Partners

$47.5→$42.5

Buy

28.94%

Upside

Reiterated

05/29/25

Global Medical REIT (GMRE) Receives a Buy from Alliance Global Partners

Unknown Analyst

Berenberg Bank

Not Ranked

Berenberg Bank

$58.75

Buy

78.25%

Upside

Reiterated

05/08/25

John Massocca

B. Riley Securities

$45

Hold

36.53%

Upside

Reiterated

04/03/25

Global Medical REIT transferred with Neutral rating at B. RileyGlobal Medical REIT transferred with Neutral rating at B. Riley

Stocks with the Highest Top Analyst Consensus in the Real Estate Sector

xxx

Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Global Medical REIT

1 Month

xxx

Success Rate

13/23 ratings generated profit

Average Return

+1.93%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.52% of your transactions generating a profit, with an average return of +1.93% per trade.

3 Months

xxx

Success Rate

13/23 ratings generated profit

Average Return

+2.20%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 56.52% of your transactions generating a profit, with an average return of +2.20% per trade.

1 Year

Merrill RossCompass Point

Success Rate

8/13 ratings generated profit

Average Return

+6.30%

reiterated a buy rating 3 months ago

Copying Merrill Ross's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +6.30% per trade.

2 Years

xxx

Success Rate

7/13 ratings generated profit

Average Return

+11.56%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 53.85% of your transactions generating a profit, with an average return of +11.56% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GMRE Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GMRE has received 3 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. GMRE average Analyst price target in the past 3 months is 38.38.

Each month's total comprises the sum of three months' worth of ratings.

GMRE Financial Forecast

GMRE Earnings Forecast

Next quarter’s earnings estimate for GMRE is $0.08 with a range of -$0.03 to $0.23. The previous quarter’s EPS was -$0.45. GMRE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.39% of the time in the same period. In the last calendar year GMRE has Performed in-line its overall industry.

GMRE Sales Forecast

Next quarter’s sales forecast for GMRE is $37.39M with a range of $37.00M to $38.81M. The previous quarter’s sales results were $40.56M. GMRE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year GMRE has Performed in-line its overall industry.

GMRE Stock Forecast FAQ

What is GMRE’s average 12-month price target, according to analysts?

Based on analyst ratings, Global Medical REIT’s 12-month average price target is 38.38.

What is GMRE’s upside potential, based on the analysts’ average price target?

Global Medical REIT has 16.44% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GMRE a Buy, Sell or Hold?

Global Medical REIT has a consensus rating of Moderate Buy which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.

What is Global Medical REIT’s price target?

The average price target for Global Medical REIT is 38.38. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $41.00 ,the lowest forecast is $35.00. The average price target represents 16.44% Increase from the current price of $32.96.

What do analysts say about Global Medical REIT?

Global Medical REIT’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of GMRE?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Global Medical REIT (GMRE) Stock Forecast & Price Target

GMRE Analyst Ratings

GMRE Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Global Medical REIT

GMRE Analyst Recommendation Trends

GMRE Financial Forecast

GMRE Earnings Forecast

GMRE Sales Forecast

GMRE Stock Forecast FAQ

Detailed List of Analyst Forecasts